CQUniversityBrowse

File(s) not publicly available

Reversal of cardiovascular remodelling with candesartan

journal contribution
posted on 2017-12-06, 00:00 authored by L Brown, Andrew FenningAndrew Fenning, A Shek, D Burstow
Cardiovascular remodelling, defined as ventricular and vascular hypertrophy together with fibrosis, characterises hypertension following inhibition of the production of the endogenous vasodilator, nitric oxide (NO). This is an abbreviated abstract.

Funding

Category 1 - Australian Competitive Grants (this includes ARC, NHMRC)

History

Volume

2

Issue

1

Start Page

141

End Page

147

Number of Pages

7

ISSN

1470-3203

Location

United Kingdom

Publisher

Sage

Publisher DOI

Full Text URL

Language

en-aus

Peer Reviewed

Yes

Open Access

No

External Author Affiliations

Prince Charles Hospital; School of Biomedical Sciences; University of Queensland;

Era Eligible

No

Journal

Journal of the renin-angiotensin-aldosterone system.

Usage metrics

CQUniversityCQUniversity

Categories

Keywords

RAAS inhibitionNitric oxideCardiovascular remodellingVascular dysfunctionL-NAMECandesartanCardiology (incl. Cardiovascular Diseases)Pharmacology and Pharmaceutical Sciences not elsewhere classifiedBasic Pharmacology

Licence

CQUniversity General 1.0

Exports